Cara Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2018 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Cara Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2018 to 2023.
  • Cara Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.23 USD/shares, a 55.8% increase year-over-year.
  • Cara Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -1.76 USD/shares, a 18.1% increase year-over-year.
  • Cara Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -2.19 USD/shares, a 37.7% decline from 2022.
  • Cara Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -1.59 USD/shares, a 8.62% increase from 2021.
  • Cara Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -1.74 USD/shares, a 1067% decline from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 -$1 -37.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-06
2022 -$2 +$0.15 +8.62% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-06
2021 -$2 -$2 -1067% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-06
2020 $0.18 +$2.67 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 -$2 $0 -20.9% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 -$2 Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.